Drug development & RnD supportPublished: September 21, 2018
Starting this month, inhive data scientists will support one of the biggest pharma companies in Germany with on-site hands-on modelling in the R&D drug development sector. Our experienced specialists are responsible for cutting-edge technological methods and know-how to answer questions on inhibitor-protein interactions. We are proud to help generate new insights, and directly apply our expertise to ongoing drug development projects!
Piloting of NAVIFY Tumor Board startedPublished: August 28, 2018
The University of Missouri School of Medicine is one of the first Roche partners implementing the NAVIFY Tumor Board solutions for a first piloting phase. The NAVIFY Tumor Board solution is designed to streamline and standardize tumor board workflows digitally, reducing manual steps to a minimum, while optimizing the benefit for the cancer patient due to effective meetings. Being part of the story, inhive is proud to see Tumor Board taking the next steps. For more information follow https://medicine.missouri.edu/news/charting-course-future-tumor-boards .
IBM Watson – what’s behind?Published: July 15, 2018
Exciting symposium on cognitive computing and AI to advance precision medicine with data scientists from IBM giving insights into their recent techniques for predictive models and research projects such as drug discovery and metabolic networks. This event is organized by DayOne and baselarea.swiss taking place on July 20 at Hotel Stücki in Basel.